Adc Therapeutics Sa

ADC Therapeutics SA is a clinical-stage oncology-focused biotechnology company pioneering the development of highly targeted antibody drug conjugates (ADCs) for treating both solid tumors and hematological malignancies. The company's proprietary technology uses monoclonal antibodies to deliver potent cytotoxic agents directly to cancer cells, thereby minimizing systemic exposure to toxic payload while maximizing therapeutic efficacy. ADC Therapeutics is committed to translating its innovative ADC platform into novel cancer therapies to address the significant unmet medical needs of patients worldwide.